多瑞医药：控股股东西藏嘉康解除质押1546.00万股

Core Viewpoint - Duori Pharmaceutical (301075) announced that its controlling shareholder, Tibet Jiakang Times Technology Development Co., Ltd., has completed the release of part of its pledged shares, totaling 15,460,000 shares [1] Summary by Relevant Categories Share Pledge Information - The released pledged shares amount to 15,460,000 shares [1] - After the release, Tibet Jiakang holds a total of 9,134,408 pledged shares, which represents 19.57% of its total holdings [1] - The pledged shares account for 11.42% of the company's total share capital [1]